Mupirocin kills bacteria by blocking a specific enzyme they need to build proteins. Without this enzyme, bacteria can’t assemble the proteins required to grow and survive, so they either stop multiplying or die. It’s one of the few antibiotics used almost exclusively on the skin and inside the nose, and its unusual mechanism is what makes it effective against common skin infections like impetigo and MRSA.
The Enzyme Mupirocin Targets
Every living cell needs to build proteins to function, and that process starts with linking amino acids together in the right order. One essential step involves an enzyme called isoleucyl-tRNA synthetase, which attaches the amino acid isoleucine to a carrier molecule so it can be incorporated into a growing protein chain. Mupirocin latches onto the active site of this enzyme in bacterial cells, competing with both isoleucine and the energy molecule ATP for the same spot. This binding is reversible, meaning mupirocin doesn’t permanently destroy the enzyme, but as long as the drug is present in sufficient concentration, it effectively shuts down the enzyme’s activity.
With isoleucyl-tRNA synthetase blocked, bacteria can’t incorporate isoleucine into their proteins. Protein synthesis stalls, and because proteins are involved in virtually every bacterial function, the cell can’t maintain itself or reproduce. At lower concentrations, mupirocin slows bacterial growth (bacteriostatic). At higher concentrations, like those achieved by applying it directly to the skin, it can kill bacteria outright (bactericidal).
Why It Doesn’t Harm Your Own Cells
Human cells have their own version of isoleucyl-tRNA synthetase, but the structure of the human enzyme is different enough from the bacterial version that mupirocin doesn’t bind to it effectively. This selectivity is a key reason the drug works well as a topical antibiotic: it targets bacteria on the skin while leaving your cells alone. The structural differences between bacterial and human versions of this enzyme are significant enough that mupirocin has essentially no effect on human protein synthesis at therapeutic concentrations.
Where Mupirocin Comes From
Mupirocin is a naturally occurring compound produced by the bacterium Pseudomonas fluorescens through fermentation. It belongs to a chemical class sometimes called pseudomonic acids. Its structure is unusual compared to other antibiotics, which is part of why bacteria that are resistant to other drug classes often remain susceptible to mupirocin. There’s no cross-resistance with antibiotics like penicillins, erythromycin, or tetracyclines because the mechanism is completely different.
What It’s Used For
Mupirocin is most commonly prescribed for bacterial skin infections, particularly impetigo. The standard approach is applying a 2% ointment to the affected area three times daily for up to 10 days. If you don’t see improvement within three to five days, that’s generally a signal to follow up with your provider, as the bacteria involved may not be responding.
The other major use is nasal decolonization for MRSA (methicillin-resistant Staphylococcus aureus). Many people carry MRSA in their nostrils without symptoms, but this colonization can lead to infections, especially before surgery. The standard decolonization protocol involves applying mupirocin nasal ointment twice daily for five days. This is a relatively low-cost intervention that meaningfully reduces surgical site infection risk.
Minimal Absorption Through the Skin
One of mupirocin’s practical advantages is that it stays where you put it. When applied to intact skin, systemic absorption is essentially undetectable. In studies where labeled mupirocin ointment was applied to the forearm and covered for 24 hours, blood levels remained below measurable thresholds (less than 1.1 nanograms per milliliter). Any small amount that does reach the bloodstream is rapidly broken down into an inactive form and cleared by the kidneys. This near-zero systemic absorption is why side effects are almost entirely limited to the application site.
Damaged or open skin is a different situation. The ointment base contains polyethylene glycol, which can be absorbed through wounds and is processed by the kidneys. For people with significant kidney problems, this absorption can be a concern when treating large open wounds.
Common Side Effects
Mupirocin is well tolerated by most people. The most frequently reported reaction is mild contact dermatitis at the application site: burning, stinging, or minor pain. Less common effects include itching, dry skin, or redness. When used inside the nose, some people notice local irritation and an unpleasant taste or smell. These side effects are typically mild and resolve on their own.
How Bacteria Develop Resistance
Resistance to mupirocin happens through two distinct routes, and understanding them helps explain why overuse is a concern.
Low-level resistance occurs when bacteria develop small mutations in their native isoleucyl-tRNA synthetase gene. These mutations subtly change the enzyme’s shape so mupirocin doesn’t bind as tightly, but the drug can still work at higher concentrations. Bacteria with low-level resistance can typically tolerate mupirocin concentrations of 8 to 64 micrograms per milliliter.
High-level resistance is a bigger problem. It happens when bacteria acquire an entirely separate gene, most commonly called mupA, that codes for an alternative version of the target enzyme. This alternative enzyme can do the same job as the original but is structurally different enough that mupirocin can’t block it at all. Bacteria carrying mupA can survive mupirocin concentrations of 512 micrograms per milliliter or higher. A second gene called mupB, which shares about 65% of its DNA sequence with mupA, produces a similar effect. Both genes are carried on transferable genetic elements called plasmids, meaning bacteria can pass them to neighboring bacteria, potentially spreading resistance through a community.
This is the main reason mupirocin is reserved for specific, short-course uses rather than applied broadly or for extended periods. Limiting exposure helps preserve its effectiveness, particularly for MRSA decolonization, where few topical alternatives exist.